The development of scalable and sensitive technologies, such as next generation sequencing (NGS) and quantitative PCR (qPCR), has revolutionized genomics by enabling nucleic acids of almost any sequence to be amplified and quantified with relative ease using standard chemistries, revealing contextual insights into the complete genome and transcriptome. Proteins, on the other hand, the study of which are important for understanding a range of biological conditions, including inflammation, cell regulation, immune responses, and oncology, are not as amenable to analysis. In fact, most technologies for proteomics have lagged compared to their genomic counterparts, especially in terms of throughput, specificity, and cost.

Read more…